1. COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
   Sujie Gu et al, 2021, Frontiers in Oncology CrossRef
2. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
   Yajing Mi et al, 2020, Frontiers in Immunology CrossRef
3. Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment
   Yuxiang Fan et al, 2021, Frontiers in Immunology CrossRef
4. Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia
   Shih-Chung Yen et al, 2021, Journal of Natural Products CrossRef
5. Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis
   Fang Cao et al, 2021, Cancer Management and Research CrossRef
6. Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy
   Ruth M. Urbantat et al, 2021, International Journal of Molecular Sciences CrossRef
7. RID: Evaluation of the Possible Inhibiting Effect of the Proinflammatory Signaling Induced by TNF-α through NF-κβ and AP-1 in Two Cell Lines of Breast Cancer
   F. A. Monsalve et al, 2020, Mediators of Inflammation CrossRef
8. Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment
   Elena Codrici et al, 2022, International Journal of Molecular Sciences CrossRef